TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
STOK

Stoke Therapeutics Inc

Healthcare · Biotechnology

28.90$ +3.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

Stoke Therapeutics Inc (STOK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 46 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow STOK
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-5.4 -11 -31 -42 -67 -32 -81 -87 46
0.1 0.2 0.5 0.9 1.0 1.5 2.5 2.2 1.8
0.0 0.2 1.9 5.8 16 23 25 27 32
0.0 0.3 1.9 5.8 16 23
0.0 1.1 -1.1 2.3 0.0 43 -6.0 -28 16
0.1 0.9 1.6 1.1 1.2 4.0 1.6 0.2 0.7
-0.1 -0.9 -1.6 -1.1 -76 -46 106 -107 -187
0.0 0.0
6.0 116 152 108 1.3 1.1
0.0 0.0 -0.2
6.0 116 150 108 1.3 46 53 131 97
0.5 104 117 65 -142 -31 78 -63 -44
-5.5 -12 -33 -43 -68 -36 -83 -87 45

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?